Panagora Asset Management Inc Verastem, Inc. Transaction History

Panagora Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $160,773 - $288,446	-157,621 Reduced 93.98%	10,102 $12,000
Q1 2022 May 12, 2022	SELL	$1.06 - $2.1 $802,842 - $1.59 Million	-757,399 Reduced 81.87%	167,723 $236,000
Q4 2021 Feb 10, 2022	SELL	$2.05 - $3.2 $313,258 - $488,988	-152,809 Reduced 14.18%	925,122 $1.9 Million
Q3 2021 Nov 10, 2021	BUY	$2.54 - $4.07 $49,446 - $79,230	19,467 Added 1.84%	1,077,931 $3.32 Million
Q2 2021 Aug 11, 2021	BUY	$2.57 - $4.85 $172,405 - $325,357	67,084 Added 6.77%	1,058,464 $4.31 Million
Q1 2021 May 12, 2021	SELL	$1.9 - $2.82 $55,282 - $82,050	-29,096 Reduced 2.85%	991,380 $2.45 Million
Q4 2020 Feb 10, 2021	BUY	$1.15 - $2.4 $587,131 - $1.23 Million	510,549 Added 100.12%	1,020,476 $2.17 Million
Q3 2020 Nov 13, 2020	BUY	$1.11 - $1.68 $566,018 - $856,677	509,927 New	509,927 $617,000
Q4 2018 Feb 14, 2019	SELL	$3.23 - $7.01 $596,309 - $1.29 Million	-184,616 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.88 - $8.67 $467,896 - $1.41 Million	162,464 Added 733.41%	184,616 $1.27 Million
Q4 2017 Feb 14, 2018	SELL	$2.99 - $4.85 $1,892 - $3,070	-633 Reduced 2.78%	22,152 $68,000
Q3 2017 Nov 14, 2017	BUY	$3.01 - $5.41 $68,582 - $123,266	22,785	22,785 $107,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.